Your SlideShare is downloading. ×
FP722May07_slides_AR_AS_Athens.ppt
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

FP722May07_slides_AR_AS_Athens.ppt

485
views

Published on

Published in: Technology

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
485
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Directorates Generals involved in Research and contributing to FP7-
    Research
    Information Society and Communication
    Transport and Energy
    Enterprise
    Fishery
  • Cooperation- Collaborative Research
    The largest one
  • <number>
  • <number>
  • <number>
  • <number>
  • <number>
  • <number>
  • <number>
  • <number>
  • Updated 250/10/2006 per A. O’Rourke
  • <number>
  • Transcript

    • 1. 7th Framework Program 2007-2013 Achilleas D. Stalios Achilleas.Stalios@ec.europa.eu European Commission -DG Research- Industrial Technologies Directorate -Materials-
    • 2. Funding programmes Education - Lifelong Learning Programme Research- FRAMEWORK PROGRAMMES - Seventh Framework Programme for research and development Innovation - Competitiveness and Innovation Programme Structural and Cohesion Funds
    • 3. R&D – European weaknesses EU-25 US Japan R&D intensity (% of GDP) (3) 1.97 2.59 3.12 Share of R&D financed by industry (%) (2) 55.9 63.1 73.9 Researchers per thousand labour force (FTE) (3) 5.5 9.0 9.7 Share of world scientific publications (%) (3) 38.3 31.1 9.6 Scientific publications per million population (3) 639 809 569 Share of world triadic patents (%) (1) 31.5 34.3 26.9 Triadic patents per million population (1) 30.5 53.1 92.6 High-tech exports as a share of total manufacturing exports (%) (3) 19.7 28.5 26.5 Share of world high-tech exports (%) (2) 16.7 20.0 10.6 Note: (1) 2000 data (2) 2002 data (3) 2003 data
    • 4. Towards The 7th Framework Programme 2007-2013 (‘co-decision’)
    • 5. New FP7 FP7 : What’s new? Main elements:  Duration increased to seven years  Total budget of €50.5 billion=>63% increase  Frontier research (~ €1.1 billion per year)  New structure: Cooperation – Ideas – People – Capacities  Flexible funding schemes  Joint Technology initiatives  Simpler procedures  Outsourcing http://ec.europa.eu/research/fp7/events/07_feb_07_prog_en.html
    • 6. FP7 2007 –2013 Specific Programmes + Ideas – Frontier Research Capacities – Research Capacity People – Marie Curie Actions Cooperation – Collaborative research JRC (non-nuclear) JRC (nuclear) Euratom
    • 7. FP7/ Budget Cooperation 32 413 €M Ideas 7 460 €M People 4 728 €M Capacities 4 217 €MNon-nuclear JRC 1 751 €M Total European Community budget for non-nuclear research: 50.52 € billions
    • 8. FP7/ Cooperation programme http://cordis.europa.eu/fp7/cooperation
    • 9. Funding Schemes • Collaborative projects – Projects can range from small or medium-scale focused research actions (CP) – Large scale integrating projects for achieving a defined‑ objective. (Large CP) • Coordination and support actions – Support for activities aimed at coordinating or supporting research activities and policies (networking, exchanges, trans-national access to research infrastructures, studies, conferences, etc.). (CA) and (SSA) • Networks of Excellence FP7/ Cooperation programme
    • 10. FP7 /Cooperation programme (collaborative research) 10 Themes 1. Health 2. Food, agriculture & fisheries and biotechnology 3. Information Society and Communication Technologies -> ICT 4. Nanosciences, nanotechnologies, Materials & new Production technologies -> NMP 5. Energy 6. Environment (including climate change) 7. Transport (including aeronautics) 8. Socio-economic sciences & the humanities M€ 1 430/80.3 31 May 1 400/34.5 19 Jun 623/58.5 10 May 4 160/229 3 May 1 890/200 2 May 2 350/237 3 May 3 475/364 4May1st 9 050/1019 8 May 1 935/192 2 May 6 100/628 19 April
    • 11. 4. Nanosciences, Nanotechnologies, Materials and new Production Technologies • Nanosciences and nanotechnologies • Materials • New production • Integration of technologies for industrial applications Workprogrammes include indicative priorities for future calls!!!
    • 12. NMP-2007-2.1.1 Large CP Nanostructured polymer-matrix composites NMP-2007-2.1.2 CP Nanostructured coatings and thin films NMP-2007-2.2-1 Large CP Organic materials for electronics and photonics NMP-2007-2.2-2 CP Nanostructured materials with tailored magnetic properties NMP-2007-2.2-3 CP Advanced material architectures for energy conversion NMP-2007-2.3-1 Large CP Highly porous bioactive scaffolds controlling angiogenesis for tissue engineering NMP-2007-2.4-2 CP Nanostructured catalysts with tailor-made functional surfaces NMP-2007-2.4-3 CP Renewable materials for functional packaging applications NMP-2007-2.5-2 CP Modelling of microstructural evolution under work conditions and in materials processing Selected topics in Materials andSelected topics in Materials and Nanotechnology in FP7Nanotechnology in FP7NanomaterialsNanomaterials
    • 13. ENERGY-2007.1.2.4 CP Novel nanostructured materials for hydrogen storage ENERGY-2007.1.1.1 CP Basic research for materials and processes for Polymer Electrolyte Membrane Fuel Cells (PEMFC) ENERGY-2007.1.1.2 CP Basic research on materials and processes for High Temperature Fuel Cells (SOFC & MCFC) ENERGY-2007.1.2.1 CP New materials and processes for advanced electrolysers ENERGY-2007.1.2.2 CP New materials and processes for advanced multi-fuel processors AAT-2007.1.1.2 CP, CSA Aerostructures Nanomaterials –cont’dNanomaterials –cont’d ICT-2007.3.1 CP, NoE, CSA Next generation nanoelectronics components and electronics integration ICT-2007.8.1 CP, CSA (CA only) Nano-scale ICT devices and systems NanoelectronicsNanoelectronics
    • 14. NanoscienceNanoscience NMP-2007-1.1-1 CP Nano-scale mechanisms of bio/non-bio interactions NMP-2007-1.1-2 CP Self-assembling and self-organisation NMP-2007-1.1-3 CSA Support to ICPC researchers in nanotechnology and creation of a free and open electronic archive of nanosciences and nanotechnologies scientific and technical publications NMP-2007-1.1-4 CSA Development of methodology, collection and elaboration of scientific-technical and socio-economic data and studies on nanosciences and nanotechnologies, including risk assessment, and establishment of an observatory NMP-2007-1.1-5 CSA (ERANET) ERANET Plus in nanosciences
    • 15. NMP-2007-1.2-1 Large CP Pilot lines to study, develop and up-scale nanotechnology- based processes from laboratory NMP-2007-1.2-2 SME-targeted CP Equipment and methods for nanotechnology NMP-2007-1.2-3 CSA Analysis of the ethical, regulatory, social and economic environment of nanomedicine NMP-2007-1.2-4 CSA Coordination in nanometrology NMP-2007-1.2-5 CSA Examining capacity building in nanobiotechnology NMP-2007-3.4-1 SME-targeted CP Rapid Manufacturing Concepts for Small Series Industrial Production NMP-2007-3.5-1 Large CP Processes and Equipment for High Quality Industrial Production of 3-Dimensional Nanosurfaces NMP-2007-3.5-2 Large CP Production Technologies and equipment for Micro- Manufacturing NMP-2007-4.0-3 SME-targeted CP Multifunctional materials for future vehicles Technology developmentTechnology development
    • 16. NMP-2007-1.3-1 Large CP Specific, easy-to-use portable devices for measurement and analysis NMP-2007-1.3-2 CP Risk assessment of engineered nanoparticles on health and the environment NMP-2007-1.3-3 CSA Scientific review on the data and studies on the potential impact on health, safety and the environment of engineered nanoparticles NMP-2007-1.3-4 CSA Creation of a critical and commented database on the health, safety and environmental impact of nanoparticles NMP-2007-1.3-5 CSA Coordination in studying the environmental, safety and health impact of engineered nanoparticles and nanotechnology based materials and products HEALTH-2007-1.3-4 CP Alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics SiS-2007-1.2.3.2-CT CSA Science in Society: Nanoscience and Nanotechnology Impact assessment and societal issuesImpact assessment and societal issues
    • 17. NMP-2007-4.0-4 Large CP Substantial innovation in the European medical industry: development of nanotechnology-based systems for in-vivo diagnosis and therapy (in coordination with topics HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3) HEALTH-2007-2.4.1-7 CP Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy HEALTH-2007-1.2.3 Large CP Novel targeted imaging probes for early in vivo diagnosis and/or evaluation of response to therapy HEALTH-2007-1.4.4 Large CP 2nd call Development of emerging gene therapy tools and technologies for clinical application ICT-2007-5.1 Large CP, CSA Personal Health Systems for Monitoring and Point-of-Care diagnostics NanomedicineNanomedicine
    • 18. ICT-2007.3.6 CP, NoE, CSA 2nd call* Micro/nanosystems ICT-2007.3.5 CP, NoE, CSA 2nd call Photonic components and subsystems ICT-2007-C CP, CSA (CA only) FET (Future and Emerging Technologies) Open (Open call for bottom-up activities) AAT-2007.6.1.4 CP, CSA Life-cycle [of air vehicles, including increased use of nanotechnologies] KBBE-2007-2-3-04 CP Nano-devices for quality assurance, food safety and product properties KBBE-2007-2-4-04 CP Innovative and safe packaging KBBE-2007-2-5-02 CP Converging technologies and their potential for the food area Other Important TopicsOther Important Topics * 2nd for ICT call will be public May/June 2007
    • 19. 1. S/T quality (in relation to the topics addressed by the call) 2. Implementation 3. Impact • Sound concept, and quality of objectives • Progress beyond the state-of-the-art • Quality and effectiveness of the S/T methodology and work plan • Appropriateness of the management structure and procedures • Quality and relevant experience of the individual participants • Appropriate allocation and justification of committed resources • Contribution to impacts listed in the work programme under relevant topic/activity • Appropriateness of dissemination and/or exploitation of projects results, plans FP7 /Collaborative projects Evaluation Criteria
    • 20. Potential Joint Technology Initiative: – New Nanoelectronics Approaches – Hydrogen and Fuel Cells for Sustainable Energy Future – Aeroanutics and Air Transport – Global Monitoring for Environment and Securitu – Embedded Systems – Innovative Medicines Initiative Technology Platforms related to Theme 4: – ENIAC: European Nanoelectronics Initiative Advisory Council – NanoMedicine- Nanotechnologies for Medical Applications – Technology Platform on Sustainable Chemistry – Steel – Future Textiles & Clothing – Manufacturing Technologies – The European Construction Technology Platform – Industrial Safety – The European Hydrogen and Fuel Cell Technology Platform – The European Technology Platform on Photovoltaics – Photonics 21: The Photonics Technology Platform – EUMAT: European TP for Advanced Engineering Materials and Technologies – European Aluminum Technology Platform
    • 21. FP7/ Ideas • Frontier research • Investigator-driven • Support to individual teams through Europe-wide competition • Governance: European Research Council • Executive Agency http://cordis.europa.eu/fp7/ideas
    • 22. FP7/ Ideas Scientific Council • 22 high level scientists reflecting the full scope of European research, nominated by Commission Dr. Claudio BORDIGNON (IT) Professor Manuel CASTELLS (ES) Prof. Dr. Paul J. CRUTZEN (NL) Prof. Mathias DEWATRIPONT (BE) Dr. Daniel ESTEVE (FR) Prof. Pavel EXNER (CZ) Prof. Dr. Hans-Joachim FREUND (DE) Prof. Wendy HALL (UK) Prof. Dr. Carl-Henrik HELDIN (SE) Prof. Dr. Fotis C. KAFATOS (GR) Prof. Dr. Michal KLEIBER (PL) Prof. Norbert KROO (HU) Prof. Maria Teresa V.T. LAGO (PT) Dr. Oscar MARIN PARRA (ES) Prof Robert MAY (UK) Prof. Helga NOWOTNY (AT) Prof. Christiane NÜSSLEIN-VOLHARD (DE) Dr. Leena PELTONEN-PALOTIE (FI) Prof. Alain PEYRAUBE (FR) Dr. Jens R. ROSTRUP-NIELSEN (DK) Prof. Salvatore SETTIS (IT) Prof. Dr. Rolf M. ZINKERNAGEL (CH) http://europa.eu.int/erc/
    • 23. FP7 / Ideas Role of the Scientific Council • Establish overall scientific strategy and preparation of work programmes (incl. calls for proposals, evaluation criteria) • Define scientific management: peer review methodology; selection and accreditation of experts; monitor quality of operations and evaluate programme implementation • Assure communication with the scientific community
    • 24. Two streams of activity are foreseen: - Early stage independent investigators (“Starting Grants”) > 2 < 9 years after PhD up to 5 years project ~1/3 of the annual budget: 300-350 M€ per year (200 grants) - Established Investigators (“Advanced Grants”) FP7 / Ideas Work Programme / Launch strategy
    • 25. FP7 / IDEAS Starting Grants / Evaluation criteria 1. Principal Investigator: Potential to perform world class research Quality of research output: Has the Principal Investigator published in high quality peer reviewed journals or the equivalent? To what extent are these publications ground-breaking and demonstrative of independent creative thinking and capacity to go significantly beyond the state of the art? Intellectual capacity and creativity: To what extent does the Principal Investigator's record of research collaborations, project conception, supervision of students and publications demonstrate that he/she isable to confront major research challenges in the field, and to initiate new productive lines of thinking? 2. Quality of the proposed research project Ground-breaking nature of the research: Does the proposed research address important challenges in the field(s) addressed? Does it have suitably ambitious objectives, which go substantially beyond thecurrent state of the art (e.g. including trans-disciplinary developments and novel or unconventiona approaches)? Potential impact: Does the research open new and important scientific, technological or scholarly horizons? Methodology: a) is the outlined scientific approach (including the activities to be undertaken by the individual team members) feasible? (Stage 1) b) is the proposed research methodology (including when pertinent the use of instrumentation, other type of infrastructures etc.) comprehensive and appropriate for to the project? Will it enable the goals of the project convincingly to be achieved within the timescales and resources proposed and the level of risk associated with a challenging research project? (Stage 2) 3. Research Environment Transition to independence: Will the proposed project enable the Principal Investigator to make or consolidate the transition to independence? Hosting institution (normally applicant legal entity): Does the institution hosting the project have most of the infrastructure necessary for the research to be carried out? Is it in a position to provide an appropriate intellectual environment and infrastructural support and to assist in achieving the ambitions for the project and the Principal Investigator? Participation of other legal entities: If it is proposed that other legal entities participate in the project, in addition to the applicant legal entity, is their participation fully justified by the scientificadded value they bring to the project?
    • 26. FP7 / IDEAS Starting Grants / Evaluation criteria
    • 27. FP7 / Ideas Starting Grants / Peer review panel Social Sciences SH1 Individuals and organisations: Economics, management, demography, geography, urban and environmental studies. SH2 Institutions, behaviour, values and beliefs: Anthropology, sociology, political science, law, communication, social studies of science and technology. SH3 The human mind and its complexity: Cognition, linguistics, psychology and philosophy. SH4 Cultures and cultural diversity: Literature, visual and performing arts, music and cultural studies. SH5 The study of the past and of cultural artefacts: Memory, history and archaeology.
    • 28. FP7 / Ideas Starting Grants / Peer review panel Natural Sciences & Engineering PE1 Mathematical foundations: Pure and applied mathematics, theoretical computer science and mathematical physics. PE2 Fundamental constituents of matter: High energy, particle, nuclear, plasma, atomic, molecular, gas and optical physics. PE3 Structures and reactions: Condensed matter (structure, electronic properties, fluids,…), statistical physics, nanosciences, reactions. PE4 Material sciences and methods: Material sciences, molecular architecture, analytical chemistry, synthesis (both inorganic and organic) and theory, physical and environmental chemistry, method development. PE5 Information and communication: Informatics and information systems, communication technology, computer science, intelligent systems. PE6 Engineering sciences: Electronics, product design, process design & control, construction methods, fluid and solid mechanics, energy systems, bio- engineering. PE7 Universe sciences: Astro-physics/chemistry/biology/geology; solar system; stellar, galactic and extragalactic astronomy; cosmology; space sciences, instrumentation. PE8 Earth system science: Physical geography, geology, geophysics, oceanography, climatology, ecology, global change, biogeochemical cycles, natural resources.
    • 29. FP7 / IDEAS Starting Grants / Peer review panel Life Sciences LS1 Molecular, cellular and developmental biology: Biochemistry, molecular biology, metabolism, cell biology, signal transduction, embryology, structural biology. LS2 Genetics, genomics, bioinformatics and systems biology: Molecular genetics, cell genetics, genomics, transcriptomics, metabolomics, computational biology, biostatistics, biological modelling. LS3 Organismic physiology, including infection and immunity: Organogenesis, organ physiology, endocrinology, ageing, toxicology, parasitology, microbiology, virology, immunology. LS4 Neurosciences: Neurobiology, neuroanatomy, neurophysiology, neurochemistry, neuropharmacology, systems neuroscience, neuroimaging. LS5 Evolutionary, population and environmental biology: Evolution, adaptation, population biology, biodiversity, ecotoxicology, marine biology, radiation biology, environmental risks, environmental medicine. LS6 Applied medical and health sciences: Clinical medicine, public health, psychiatry, surgery, epidemiology, biomedical engineering, veterinary medicine, pharmacology, medical ethics. LS7 Applied biology and bioengineering, including agricultural sciences and biotechnology: Genetic engineering, GMOs, synthetic biology, plant biology, fisheries, forestry,environmental biotechnology, industrial biotechnology, biomaterials, biohazards
    • 30. OBJECTIVE-> TO MAKE EUROPE MORE ATTRATIVE FOR THE BEST RESEARCHERS http://cordis.europa.eu/fp7/people Scope • Human resource development in R&D in Europe • Numerous, well-trained, motivated researchers • Attract students to research careers • Attract researchers to Europe and retain skills and sustainable career development • Appropriate gender balance FP7 / People Human potential
    • 31. FP7 / People Activities/ 1st calls for proposals • Initial training of researchers - Marie Curie Networks FP7-PEOPLE-2007-1-1-ITN 7 May-25 Sept 2007 • Life-long training and career development – Individual Fellowships (IEF) FP7-PEOPLE-2007-2-1-IEF 14 August 2007 - Co-financing of regional/national/international programmes FP7-PEOPLE-2007-2-3-COFUND 17 Oct 2007 • Industry-academia pathways and partnerships - Industry-Academia Scheme FP7-PEOPLE-2007-3-1-IAPP 31 May 2007
    • 32. FP7 / People Activities/1st call for proposals • International dimension - Outgoing International Fellowships FP7-PEOPLE-2007-4-1-IOF 14 August 2007 - Incoming International Fellowships FP7-PEOPLE-2007-4-2-IIF 14 August 2007 - Reintegration grants FP7-PEOPLE-2007-4-3-IRG Continuous submission with "cut-off dates" for proposals received until 25 April and 17 Oct 2007 • Specific actions - Excellence awards FP7-PEOPLE-2007-5-2-AWARDS 29 March 2007 - Researchers' night FP7-PEOPLE-2007-5-1-1-NIGHT 3 April 2007
    • 33. FP7 / Capacities Research Capacity OBJECTIVE-> TO UNDERPIN THE NEEDS TO PERFORM RESEARCH http://cordis.europa.eu/fp7/capacities • Research Infrastructures INFRA-2007-2-2.27 Pan-European R I for Nano-structures 1715 M€ • Research benefit of SMEs FP7-SME-2007-1 1336 M€ • Regions of Knowledge 126 M€ • Research Potential340 M€ • Science in Society 330 M€ • International Cooperation 180 M€ • Coherent Development of Policies 70 M€
    • 34. Conditions for participation • Minimum condition, general rule, at least 3 independent participants from 3 different MS or Ac • Additional conditions can be established by the SP or WP (number or type of participant, place of establishment) • Specific conditions may also apply for: – Frontier research actions, at least 1 legal entity established in a MS or Ac – Collaborative projects addressing the participation of International Cooperation Partner Countries (ICPC) minimum is 4 participants, 2 of which from MS or Ac and another 2 from ICPC countries unless otherwise foreseen in the WP
    • 35. UpperUpper funding limits (1)funding limits (1) • Reimbursed will be according to the type of action and/or activity • Research and technological development activities: up to 50% of eligible costs, or up to 75% for: • Non profit public bodies • secondary and higher education establishments • research organisations • SMEs • Security related research, for highly reliable capabilities with impact on security of European citizens and targeted to a limited number of public users • Demonstration activities: up to 50% • Other activities including management: up to 100%
    • 36. Upper funding limits (2)Upper funding limits (2) Actions that will be reimbursed up to 100%: • Frontier research • Coordination and support actions • Training and career development of researchers
    • 37. Maximum reimbursement rates of eligible costs Research and technological development (*) Demonstration activities Management of the consortium activities Other activities (**) Network of excellence 50% 75% (***) 100% 100% Collaborative project 50% 75% (***) 50% 100% 100% Coordination and support action 100% (****) 100% (****) (*) Research and technological development includes operational activities directly related to the protection of foreground and coordination of research activities. (**) Other activities means any "specific activity" covered by Annex I. (***) For beneficiaries that are non profit public bodies, secondary and higher education establishments, research organisations and SMEs (****) The reimbursement of indirect eligible costs, in the case of coordination and support actions, may reach a maximum 7% of the direct eligible costs, excluding the direct eligible costs for subcontracting and the costs of reimbursement of resources made available by third parties which are not used on the premises of the beneficiary.
    • 38. Reimbursement of eligible costsReimbursement of eligible costs • Most funding schemes, particularly at beginning of FP7 will use reimbursement of eligible costs Eligible • actual (average personnel costs may be used if do not differ significantly from actual) • incurred during duration of project • in accordance with the beneficiary usual accounting and management principles • recorded in the accounts of beneficiary • used for the sole purpose of achieving the objectives of the project Non-eligible (identifiable indirect taxes including VAT…)
    • 39. Indirect CostIndirect Cost • Participants may charge eligible direct and indirect costs • Reimbursement of indirect costs: – For all: • either actual overhead, or simplified method, or • flat rate of 20% of direct costs – For Non profit Public Bodies, Secondary and Higher Education establishments, Research Organisations, and SMEs unable to identify real indirect costs, may apply for a flat rate of 60% for funding schemes with Research, Technological Development & Demonstration – For Coordination and Support Actions limit of 7% of direct costs
    • 40. Certification on the methodologyCertification on the methodology • It aims at certifying the methodology of calculating (average) personnel costs and overhead rates • Waives the obligation of certificates for interim payments • Simplified certificate for final payments • Valid throughout FP7, on a voluntary basis, must be accepted by the EC • Particularly aimed at legal entities with multiple participation
    • 41. Certification onCertification on financial statementsfinancial statements Under FP7 we do not talk anymore about audit certificates but about certificate on financial statements (CFS) Certificate on financial statements: • Mandatory when requested funding reaches 375,000 Euro per beneficiary (except for project of 2 years or less: CFS submitted at the end) • If above the threshold, mandatory for every beneficiary, except if a certification on the methodology is provided
    • 42. Risk avoidance mechanism (1)Risk avoidance mechanism (1) Participant Guarantee Fund (“the Fund”): • All beneficiaires contribute to the Fund to insure against losses of a defaulting participant • The contribution shall not exceed 5% of the EC financial contribution due to each participant • Financial interests generated by the Fund will serve to cover financial risk • In principle this amount will be reimbursed at the end of the action
    • 43. TerminologyTerminology Sources: Financial Regulation/Implementing Rules, FP7 and Rules for Participation • “Contract” becomes “Grant Agreement” • “Contractor” becomes “Beneficiary” • “Instruments” become “Funding Schemes” • “Audit certificate” becomes “Certificate on Financial Statement” • The results of the project (knowledge in FP6) becomes “Foreground” • Pre-existing know-how becomes “Background”
    • 44. Consortium agreementConsortium agreement • Unless exempted by the call for proposals, participants will have to draw up a “consortium agreement”, to govern the following: • (a) The internal organisation of the consortium • (b) The distribution of the Community financial contribution • (c) Additional rules on dissemination and use including intellectual property rights arrangements, as appropriate • (d) The settlement of internal disputes.
    • 45. Who evaluates proposals How to become evaluator for FP7 Cooperation The Commission invites individuals to apply as prospective independent experts in order to be included in its database of experts for the Seventh Framework Programme http://cordis.europa.eu/emmfp7
    • 46. Who evaluates proposals How to become evaluator for FP7 Ideas The Commission has invited the Member States to submit candidates as independent experts in order to be included in its specific database as panel Chairs and panel members and a pool of referees. Panel Chairs are expected to be internationally recognised, senior scientists in their fields. Panel members are expected to be senior scientists in their fields, actively pursuing research at the front line.
    • 47. Further information Information research programmes projects: http://cordis.europa.eu/fp7 EU research: http://europa.eu.int/comm/research RTD info magazine: http://europa.eu.int/comm/research/rtdinfo
    • 48. Single Helpdesk: Research Enquiries Service http://ec.europa.eu/research/enquiries

    ×